Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2271842/pacific-biosciences-pacb-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271842
May 09, 2024 - While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Compared to Estimates, EverCommerce (EVCM) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2271843/compared-to-estimates-evercommerce-evcm-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2271843
May 09, 2024 - While the top- and bottom-line numbers for EverCommerce (EVCM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271839/health-catalyst-hcat-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271839
May 09, 2024 - The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271841/natera-ntra-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271841
May 09, 2024 - The headline numbers for Natera (NTRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Integral Ad Science (IAS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271840/integral-ad-science-ias-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271840
May 09, 2024 - The headline numbers for Integral Ad Science (IAS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2271845/compared-to-estimates-guardant-health-gh-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2271845
May 09, 2024 - Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q1 Earnings
https://www.zacks.com/stock/news/2271844/here-s-what-key-metrics-tell-us-about-beauty-health-skin-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2271844
May 09, 2024 - The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Here's What Key Metrics Tell Us About Yelp (YELP) Q1 Earnings
https://www.zacks.com/stock/news/2271846/here-s-what-key-metrics-tell-us-about-yelp-yelp-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2271846
May 09, 2024 - The headline numbers for Yelp (YELP) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Chuy's (CHUY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271847/chuy-s-chuy-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271847
May 09, 2024 - While the top- and bottom-line numbers for Chuy's (CHUY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271814/collegium-pharmaceutical-coll-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271814
May 09, 2024 - The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0